Corrigendum to “Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice” [Int. Immunopharmacol. 79 (2020) 106180]
- 8 April 2020
- journal article
- correction
- Published by Elsevier BV in International Immunopharmacology
- Vol. 84, 106461
- https://doi.org/10.1016/j.intimp.2020.106461
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: